Marinomed Biotech AG

Director's Dealing • Sep 20, 2022

publication: 20.09.2022 13:32 source: http://adhoc.pressetext.com/news/1663673562086 keywords: Directors' Dealings / Eigengeschäfte von Führungskräften / Marinomed Biotech AG

Managers' transactions announcement according to article 19 MAR

Marinomed Biotech AG: Correction of a Managers' transactions announcement according to article 19 MAR from 20.09.2022

Korneuburg (pta029/20.09.2022/13:32) - Announcement

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Brigitte Ederer
2	Reason for the notification
a)	Position/status	Member of Supervisory Board
b)	Amendment	Correction of the aggregated volume under 4d
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Marinomed Biotech AG
4	Details of the transaction(s)
a)	Description of the financial instrument, type of instrument	Share
	Identification code	ATMARINOMED6
b)	Nature of the transaction	Purchase
c)	Price(s)	Volume(s)
	63.20	100
d)	Aggregated price	Aggregated volume
	63.20	6,320
e)	Date of the transaction	15.09.2022 UTC+2
f)	Place of the transaction	Vienna Stock Exchange
	MIC	XWBO

emitter:	Marinomed Biotech AG Hovengasse 25 2100 Korneuburg Austria
contact person:	Pascal Schmidt, CFO
phone:	+43 2262 90300
e-mail:	pascal.schmidt@marinomed.com
website:	www.marinomed.com
ISIN(s):	ATMARINOMED6 (share)
stock exchanges:	official trade in Vienna

News transmitted by pressetext.adhoc. The emitter is responsible for the content.